Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genomics and the prospects of existing and emerging therapeutics for cardiovascular diseases.

Current pharmaceutical design - 1 Jan 2009

Zaiou M, Benachour H, Marteau J B, Visvikis-Siest S, Siest G

Abstract excerpt

The growing knowledge about genetic influence on cardiovascular diseases (CVD) combined with the recently generated amounts of genomic data hold promise to the identification of new markers for atherosclerotic CVD. Cardiovascular pharmacogenomics and pharmacogenetics have now the potential for leading to identification of genetic contributors and therefore to the development of predictive genetic tests that could...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biological Products
Share to Cardiovascular Agents
Share to Cardiovascular Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Design

Share to Patient Selection

Share to Peptides

Share to Pharmacogenetics

Share to Predictive Value of Tests

Source

Identifiers

PMID: 19754391
DOI: 10.2174/138161209789058011

Genes

ACE
APOE
HMGCR
TNF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genomics and the prospects of existing and emerging therapeutics for cardiovascular diseases.PMID 19754391Read ↗

Cardiovascular pharmacogenetics: a promise for genomically-guided therapy and personalized medicine.Semantic proximity Read ↗

Pharmacogenomics in cardiac therapy: Personalizing treatment for heart healthSemantic proximity Read ↗

Genetics of Cardiovascular Disease: How Far Are We from Personalized CVD Risk Prediction and Management?Semantic proximity Read ↗

Pharmacogenomics and cardiovascular drugs: need for integrated biological system with phenotypes and proteomic markers.Semantic proximity Read ↗

Expanding Role of Pharmacogenomics in the Management of Cardiovascular DisordersSemantic proximity Read ↗

Pharmacogenomics--10 years of progress: a cardiovascular perspective.Semantic proximity Read ↗

[Pharmacogenetics--new perspectives in the treatment of cardiovascular diseases].Semantic proximity Read ↗

Cardiovascular Pathologies: A Comprehensive Review of Mechanisms, Risk Factors, and Advanced Therapeutic ModalitiesSemantic proximity Read ↗

Personalized Management of Cardiovascular Disorders.Semantic proximity Read ↗

Cardiovascular pharmacogenetics in the SNP era.Semantic proximity Read ↗

[Cardiovascular pharmacogenomics].Semantic proximity Read ↗

Prospects for personalized cardiovascular medicine: the impact of genomics.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.